Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACON - HDR Brachytherapy, EBRT, and STAD for Recurrent Prostate Cancer
NCT03553602Phase 2Terminated
- Sponsor
- Loyola University Chicago
- Start
- Dec 2017
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial in prostate cancer (PCa), sponsored by Loyola University Chicago. Started Dec 2017; status: terminated.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03553602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553602.